Evidence
CAnimal replicated
Companion Chapter
This chapter covers GHK as a free tripeptide. The GHK-Cu chapter (covered separately, 461 paragraphs) provides comprehensive coverage of: the copper complex pharmacology; injectable systemic use protocols; wound healing mechanisms; full mechanism of action for GHK-Cu specifically; anti-aging systemic applications; safety and cancer/angiogenesis audit for the complex form. This chapter should be read as a complement to GHK-Cu — covering the endogenous biology of the free tripeptide, the copper-carrier function, the plasma decline framework, and the topical cosmetic applications specific to free or copper-chelated topical GHK.
The Plasma Decline — The Core Anti-Aging Argument
GHK plasma levels: approximately 200 ng/mL (10⁻⁷ M) at age 20, declining to approximately 80 ng/mL by age 60 — a 60% reduction over 40 years of adult life. This decline correlates temporally with the visible and measurable decrease in regenerative capacity that characterizes aging: slowed wound healing, reduced skin collagen density, diminished tissue repair, increased inflammation, decreased stem cell activity. Pickart's fundamental hypothesis: restoring GHK to younger-adult plasma levels may restore the regenerative signaling that declining levels allow to lapse. This is a restoration framework, not a pharmacological enhancement.
GHK as Copper Carrier — The Primary Endogenous Function
GHK's most characterized endogenous function is as a copper carrier/chaperone: extracting copper from plasma albumin (copper's primary plasma transport protein) and delivering it to cells and tissues requiring copper for enzyme function. Copper is an essential cofactor for: lysyl oxidase (collagen and elastin crosslinking — structural integrity of connective tissue); superoxide dismutase (antioxidant defense); cytochrome c oxidase (mitochondrial electron transport); ceruloplasmin (iron metabolism); dopamine beta-hydroxylase (catecholamine synthesis). At physiological pH, GHK's lysine residue interacts with cellular receptors (not copper binding), while glycine and histidine maintain copper chelation — allowing the peptide to function simultaneously as a copper transporter and a cellular signaling molecule.
GHK vs GHK-Cu — The Critical Potency Distinction
Pickart's 39 years of research established a clear conclusion: virtually all major biological GHK effects require the presence of copper(II) chelated to the tripeptide. Strong copper chelators (bathocuproine) abolish GHK actions. GHK-Cu is substantially more potent than GHK alone for wound healing, collagen synthesis, and most tested applications. Free GHK has copper-independent signaling activity through its lysine residue, but this activity is weaker. In vivo, free GHK plasma is believed to spontaneously acquire copper from albumin at sites of tissue damage — effectively becoming GHK-Cu at the point of action. Topical free GHK formulations acquire copper from the skin environment.
The 4,000 Gene Claim — Honest Framing
Using the Broad Institute's Connectivity Map (a database of transcriptional responses to perturbagens), Pickart showed GHK modulates the expression of over 4,000 human genes, with notable effects reversing gene expression patterns associated with aggressive cancer and COPD toward healthier states. This is real Connectivity Map data — GHK does produce widespread gene expression changes. The honest framing: gene expression modulation in a database does not automatically translate to beneficial outcomes in living organisms; the Connectivity Map analysis identifies patterns, not proven clinical effects. The 4,000 gene claim is a starting point for research, not proof of efficacy for 4,000 biological functions.
Topical Applications — The Primary GHK Basic Context
Topical GHK and GHK-Cu are the most extensively studied and most evidence-supported applications. GHK topical formulations are used in: anti-aging skincare (collagen synthesis, skin thickness, wrinkle reduction); post-procedure healing (after laser, microneedling, chemical peels); wound care; hair growth support. INCI name for cosmetics: Copper Tripeptide-1 (when complexed). Multiple small RCTs show topical GHK-Cu improves skin photoaging markers. A 2023 split-face RCT (n=60 women, 12 weeks) showed significant improvement in skin texture, wrinkle depth, and firmness vs placebo.